Skip to main content
. 2019 May 16;14:1045–1051. doi: 10.2147/COPD.S155306

Figure 1.

Figure 1

T2 inflammatory pathway and the target site for anti-IL-5 agents.

Abbreviations: CRTh2, chemoattractant receptor homolog from Th2 cells; ILC2, innate lymphoid cells; TSLP, thymic stromal lymphopoietin; IL, Interleukin.